Oura and Counsel Health Expand Partnership Through CMS ACCESS Model

The intersection of wearable technology and government-backed healthcare delivery reached a significant milestone today as smart-ring manufacturer Oura announced an ambitious expansion of its partnership with Counsel, an artificial intelligence-native primary care company. The collaboration centers on the Centers for Medicare & Medicaid Services (CMS) Innovation Center’s Advancing Chronic Care with Effective Scalable Solutions (ACCESS) Model. By leveraging this federal framework, Oura and Counsel intend to study how continuous biometric tracking, when paired with physician-led clinical intervention, can be scaled effectively to support Medicare beneficiaries managing prevalent and costly chronic conditions.

Beginning in early 2027, eligible Medicare beneficiaries across nearly all United States jurisdictions will gain access to Counsel’s specialized, AI-driven chronic care services at zero out-of-pocket cost. The initiative specifically targets four major public health challenges: hypertension, obesity, hyperlipidemia, and prediabetes. This strategic initiative builds directly upon a foundational partnership established in May, which initially sought to bridge the gap between passive health monitoring and actionable clinical advice for general consumers of the Oura Ring platform.

Understanding the Mechanics of the ACCESS Model and AI-Driven Primary Care

The CMS Innovation Center’s ACCESS Model is designed to test innovative payment and service delivery models that aim to improve health outcomes while lowering expenditures for Medicare, Medicaid, and Children’s Health Insurance Program beneficiaries. By integrating Counsel into this regulatory framework, the partnership introduces a hybrid care delivery model that merges automated computational insights with human medical expertise.

Under the terms of the program, participating Medicare beneficiaries will receive personalized clinical guidance generated by Counsel’s proprietary medical artificial intelligence. Crucially, this algorithmic support is backed by on-demand access to board-certified physicians. For patients who choose to wear the Oura Ring and explicitly consent to share their health data, the clinical equation changes fundamentally. Counsel’s care teams will ingest continuous biometric metrics—such as resting heart rate, heart rate variability, sleep architecture, and temperature trends—directly from the Oura App. This continuous data stream allows physicians to move away from episodic, reactive office visits and toward proactive, data-informed chronic disease management.

Chronology of the Partnership: From Consumer Integration to Federal Scale

The evolution of the Oura and Counsel collaboration reflects the accelerating convergence of consumer wearables and clinical medicine. In May, the two entities announced their initial integration, designed to help Oura members translate daily health metrics into tangible steps recommended by healthcare professionals. While that initial phase targeted the broader demographic of Oura users seeking lifestyle optimization and early health warnings, the new agreement scales the concept significantly by focusing on a federally insured, older demographic managing established chronic diseases.

Early metrics from the initial consumer rollout demonstrate favorable user adoption and clinical satisfaction. In the months following the May launch, Oura members utilizing the integration reported high levels of satisfaction regarding how the platform contextualized their biometric data to guide subsequent medical consultations. Notably, members who completed a consultation with a Counsel physician rated their overall care experience an impressive 4.6 out of 5 stars, signaling strong approval for the convenience and clinical quality of the hybrid care model.

Demographic Relevance: Why the Senior Population Matters to Oura and CMS

The decision to channel the ACCESS model through Oura’s existing infrastructure is underpinned by specific demographic realities within the wearable technology sector. Contrary to the assumption that smart rings and fitness trackers appeal exclusively to younger, tech-savvy demographics, data reveals that individuals aged 65 and older represent one of Oura’s most consistently engaged user cohorts, demonstrating exceptionally high daily app interaction rates.

Furthermore, internal health data highlights a compelling intersection of age, technology adoption, and chronic disease prevalence. Approximately 20% of Oura members aged 65 and older present with a Body Mass Index (BMI) of 30 or higher, placing them directly in the clinical crosshairs for obesity-related comorbidities, including hypertension and prediabetes. By deploying the ACCESS program to this specific user base, Oura and Counsel are bridging a critical gap: reaching engaged older adults who already possess the hardware and digital habits necessary for continuous health tracking, but who may benefit immensely from structured, physician-led interventions reimbursed through public healthcare channels.

Executive Perspectives and Official Statements from Leadership

Industry leaders have emphasized the paradigm shift represented by the expanded partnership, highlighting the transition from passive tracking to active, clinically validated health management.

"Earlier in the year, we partnered with Counsel to help Oura Members move from health insights to clinical action," stated Dr. Ricky Bloomfield, Chief Medical Officer at Oura. "The ACCESS program gives us the opportunity to study that model at scale, and to better understand how continuous biometric data, combined with physician-led care, can support Medicare beneficiaries managing hypertension, obesity, and other early cardio-kidney-metabolic conditions."

Dr. Bloomfield’s sentiments underscore a broader industry ambition: proving to federal regulators, healthcare economists, and traditional medical systems that consumer-grade biometric data is not merely a novelty for fitness enthusiasts, but a clinically valuable diagnostic and monitoring tool capable of managing complex, systemic illnesses.

Operational Framework: Enrollment Mechanics and Patient Privacy

As the partnership prepares for its formal rollout in early 2027, operational frameworks are being established to ensure a seamless transition for interested participants. Oura will act as an informational bridge within the digital ecosystem, utilizing the Oura App to inform eligible members about the ACCESS program and direct them toward Counsel’s intake pathways.

However, clinical governance remains strictly within the purview of licensed medical professionals. Counsel will independently evaluate clinical eligibility for the program, manage formal patient enrollment, and oversee all subsequent medical care delivered through the platform. This separation ensures compliance with federal healthcare regulations and patient privacy standards, such as the Health Insurance Portability and Accountability Act (HIPAA), governing the handling of protected health information for Medicare beneficiaries.

Broader Industry Implications and the Future of Cardio-Kidney-Metabolic Care

The inclusion of Oura and Counsel in the CMS ACCESS Model signals a broader, structural evolution in American healthcare. For decades, chronic disease management has been hampered by fragmentation—patients see doctors a few times a year, report symptoms subjectively, and manage daily care in a vacuum. Continuous biometric monitoring offers a continuous window into patient physiology, capturing subtle physiological shifts before they manifest as acute medical crises requiring costly hospitalizations.

By targeting cardio-kidney-metabolic conditions—a cluster of interconnected disorders encompassing obesity, diabetes, heart disease, and chronic kidney disease—the ACCESS model addresses the primary drivers of Medicare expenditure. If the partnership successfully demonstrates that AI-assisted primary care combined with wearable biometric data can improve health outcomes while reducing overall costs, the implications could extend far beyond this initial cohort. Success under the CMS framework could establish a regulatory and financial precedent for the broader reimbursement of consumer health technologies within public and private insurance markets alike.

As the launch date in early 2027 approaches, Oura and Counsel plan to release further details regarding specific enrollment criteria and onboarding procedures for eligible members within the Oura App ecosystem. For the aging population managing the complexities of chronic illness, this initiative represents a concerted effort to align modern technological innovation with accessible, high-touch medical support.